Quantitative analysis of collagens and fibronectin expression in human right ventricular hypertrophy by Peters, T.H.F. (Erik) et al.
278
Quantitative Analysis of Collagens and 
Fibronectin Expression in Human Right 
Ventricular Hypertrophya
T.H.F. PETERS,b,c H.S. SHARMA,b,d E. YILMAZ,b AND A.J.J.C. BOGERSc
bPharmacology, cCardiothoracic Surgery, Erasmus University Medical Center, 
Rotterdam, The Netherlands 
ABSTRACT: One of the main features in human tetralogy of Fallot (TF) is
right ventricular hypertrophy (RVH) due to pressure (sub-pulmonary stenos-
is) and volume overload (ventricular septal defect). Currently, primary correc-
tion at a young age is the treatment of choice. To unravel the role of
extracellular matrix in RVH, we examined myocardial expression of collagens
and fibronectin in TF patients with primary correction (TF1, age 0.7  0.2 yr.),
secondary surgery (TF2, age 36.9  4.6 yr), and in age-matched control pa-
tients. Sirius red staining quantified by video imaging showed significantly in-
creased interstitial staining for collagens in both TF1 and TF2 groups as
compared to respective controls. Fibronectin was expressed in extracellular
spaces, perivascular regions, and in some cardiomyocytes. Quantitative analy-
sis of fibronectin revealed increased expression in only TF1 group as compared
to respective control. Our results indicate an increased amount of myocardial
extracellular matrix deposition as a sign of fibrosis during RVH in patients
with TF.
INTRODUCTION
Tetralogy of Fallot (TF) is a common form of cyanotic congenital heart disease,
with an incidence rate of 1 out of 2,000 newborns. TF is characterized by overriding
of the aorta, a ventricular septal defect, (sub)valvular pulmonary stenosis, and right
ventricular hypertrophy (RVH), resulting in hypoxemia due to diminished pulmo-
nary flow.1 The RVH in human TF is an adaptive response of cardiomyocytes to in-
creased pressure as well as volume overload caused by (sub)pulmonary stenosis and
by ventricular septal defect, respectively. The adaptive response requires proportion-
ate increase of coronary flow or growth of the coronary vasculature, leading to my-
ocardial remodeling as well as development of fibrosis and, without treatment,
ultimately results in cardiac failure.2−5
In myocardial fibrosis, collagens and fibronectin play a prominent role. Damage
of the collagen structure compromises the myocyte support, decreases myocardial
strength and stiffness, and allows expansion of the tissue.6 Collagen fibers are orga-
nized in the collagen network, which is found in the extracellular space of the myo-
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cardium.7−10 In myocardial fibrosis a disproportionate accumulation, either reactive
or reparative, of collagen has been observed. Experimental11 and clinical data12,13
show that a rise in collagen content increases myocardial stiffness and promotes ab-
normalities of cardiac function during hypertrophy. In a morphometrical study, an
increase in fibrosis in TF was associated with an increased diameter of myocytes and
an increase of myocardial disarray.14 In addition, the perivascular accumulation of
collagen fibers may impair the vasodilator capacity of intramyocardial coronary ar-
teries and may contribute to the decrease in coronary reserve.15
Fibronectin is found in the extracellular matrix of most tissue, serving as a bridge
between cells and interstitial collagen mesh network and influencing diverse pro-
cesses, including cell growth, adhesion, migration, and wound repair.16 In rats, fetal
fibronectin was shown to have accumulated during development of cardiac hypertro-
phy by pressure overload.17 The hypertrophied heart exhibits significant qualitative
as well as quantitative changes in gene expression. The altered expression patterns
in hypertrophy include transient expression of proto-oncogenes.18 It is thought that
those changes in cardiac hypertrophy reflect a change toward an embryonic program
of gene expression.19 However, it is still not clear whether those altered expression
patterns are general markers of cardiac hypertrophy or markers of a specific parallel
pathogenic process, such as TF. Animal studies have shown that the levels of mRNA
for fibronectin and collagens were elevated in cardiac hypertrophy.17
Most attention in research on human TF has so far focused on clinical treatment
and surgical methods to limit the myocardial injury. TF patients are usually operated
on during their first year of life. The aim of early primary repair is to close the ven-
tricular septal defect and to remove the right ventricular outflow tract obstruction,
thus relieving the hypoxemia and eliminating the stimulus for the adaptive RVH as
well as preserving right ventricular function.1,20 However, after corrective surgery
some patients develop right ventricular failure due to volume-overload caused by
pulmonary regurgitation and may for this reason require further secondary corrective
surgery later in life.21,22 Histopathological studies on TF myocardial tissue reported
that the myocardial cell diameter was reduced in patients after corrective surgery, in-
dicating regression of RVH. Nevertheless, it is not yet known to what extent the RVH
in TF patients regresses. Little attention has been paid to the molecular component
of this disease. In this study, we examined the degree of fibrosis in human TF by
measuring the expression of myocardial fibrosis markers, such as fibronectin and
collagen, in right ventricular biopsies obtained during corrective surgery for TF and
comparing the data with that of age-matched patients with normal right ventricle.
MATERIALS AND METHODS
Biopsies
The present study was approved by the Medical Ethical Committee of the Uni-
versity Hospital, Erasmus University, Rotterdam. Myocardial tissue biopsies were
obtained from patients who underwent primary corrective surgery (TF1, mean age
0.7 ± 0.2 yr, N = 11), secondary surgery (TF2, mean age 36.9 ± 4.6 yr, N = 6), and
age-matched control patients. All control patients had clinically normal right ventri-
cle and underwent autograft aortic root replacement (C1, mean age 1.5 ± 0.2 yr, N =
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6 and C2, mean age 31.7 ± 4.2 yr, N = 12). Myocardial tissue was fixed in 4%
paraformaldehyde in PBS for minimal 24 h and further processed for dehydration
and embedding in paraffin for histological and immunohistochemical studies.23 
Sirius Red Staining
The total collagen in myocardial tissue specimens was stained with Sirius red
F3BA.24 Tissue sections of 6 µm thickness, were treated with 0.2% aqueous phos-
phomolybdic acid and incubated in 0.1% Sirius red. Before dehydration, the slides
were treated with 0.01N HCl and mounted. The Sirius red–stained area was deter-
mined as percentage of total tissue area using a Kontron-KS 400 (Kontron
Electronik/Zeiss, Eching, Germany) computerized image analysis system. Distribu-
tion of collagen fibers in the interstitial space as well as in the perivascular region
was measured as Sirius red–positive area. Twelve different images from each section
were analyzed to calculate the mean percentage of stained tissue area and statistical-
ly significant values were accepted at p ≤ 0.05.
Immunohistochemistry
After fixation and dehydration, the cardiac tissue was embedded in paraffin. Sec-
tions of 6 µm thickness were cut and mounted on poly-L-lysine–coated microscope
slides, followed by immunohistochemistry using the avidin-biotin complex (ABC)
method (BioGenex, San Ramon, CA). The sections were deparaffinized and
quenched for endogenous peroxidase by 2% hydrogen peroxide in methanol. Non-
specific binding sites were blocked by 10% normal goat serum. Human serum pre-
absorbed polyclonal antibodies, against human fibronectin in 1:1,000 dilution (Life
Technologies, Breda, The Netherlands), were applied as primary antiserum and the
sections were incubated at room temperature for 30 min. Negative controls were per-
formed by omission of the primary antibody. After washing in 0.5% Tween-20 in
PBS solution, the sections were incubated with mouse biotinylated anti-rabbit IgG
(BioGenex, San Ramon, CA) for 30 min and subsequently, with peroxidase conju-
gated streptavidin. Color was developed using 3,3′-diaminobenzidine tetrahydro-
chloride dehydrate (DAB) and then sections were counter-stained with hematoxylin.
Sections were mounted and visualized under the light microscope and photographed.
A semiquantitative analysis of the sections was done by two independent observers
using a staining score ranging from 0 (no staining) to 4 (very strong, dark brown,
staining) to assess the level of fibronectin expression in the myocardial tissue ob-
tained from TF patients and age-matched controls.
FIGURE 1. Right ventricular total collagen content in patients with tetralogy of Fallot.
Micrographs of right ventricular tissue obtained from patients undergoing surgery (A) for
autograft aortic root replacement (Control), (B) for primary repair due to tetralogy of Fallot
(TF1), and (C) for secondary surgery (TF2). Tissue sections were prepared and stained with
collagen-specific stain, Sirius red. Collagen fibers appear red and are localized in interstitial
and perivascular areas. Note the interstitial fibrosis in the case of TF patients. Bar = 250 µm.
(D) Significantly enhanced interstitial collagen content in TF1 group as compared to the
control. Distribution of collagen fibers in tissue was visualized under normal and polarized
light and quantified using video imaging software. Values are fold induction and shown as
mean ± SEM of sirius red–positive interstitial/total tissue area (arrows).
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RESULTS AND DISCUSSION
Sirius red staining was performed for the total collagens in order to assess the de-
gree of myocardial fibrosis. The red staining was quantified by video imaging and
showed a significantly increased interstitial and perivascular staining for total col-
lagens in TF1 (1.4 ± 0.2 fold) (FIG. 1A and D) and TF2 (1.6 ± 0.2 fold) (FIG. 1B and
1D) as compared to their respective controls (FIG. 1C and 1D). The immunolocal-
ization of fibronectin showed that fibronectin was expressed in the interstitium, in
the perivascular area, as well as in some cardiomyocytes. Semiquantitative analysis
using a staining score ranging from 0−4, revealed that the fibronectin expression was
significantly increased in TF1 (FIG. 2A and 2D) as compared to control (3.0 ± 0.2
versus 2.6 ± 0.2). There were no differences in fibronectin expression in patients
from TF2 (FIG. 2B and 2D) as compared with age-matched controls (FIG. 2C and
2D). Our results indicate an increased amount of myocardial extracellular matrix
deposition in RVH in patients with TF, with an apparent increase of total collagen
and a slight increase in fibronectin at young age. 
The apparent development of cardiac hypertrophy is induced by changes in car-
diac gene expression that provide the heart a means of compensation for increased
hemodynamic load.25 In this regard, our data are in agreement with the histopatho-
logic findings from the RV myocardium in preoperative TF, which show interstitial
fibrosis, myofibrillar disorganization, disarray, and degenerative changes, in addi-
tion to myocardial cell hypertrophy.18,26,27 The changes found in our study of ex-
pression of collagens and fibronectin could be attributed to altered structure or
function of the myocardium. It is believed that changes in gene expression accom-
panying cardiac hypertrophy are the result of a multifactorial process and the ob-
served changes may therefore be concomitant phenomena. The alteration in
ventricular gene expression might be an indicator of cardiac hypertrophy and may
result from a number of different stimuli. We assume that the changes in the right
ventricular fibronectin and collagen expression in TF patients could be as a result of
increased hemodynamic load as it has been often found to be parallel with the in-
crease in ventricular mass.19
In the case of TF patients, the early increase of collagen and fibronectin deposi-
tion in the right ventricle may occur because the original myocardial extracellular
matrix has been expanded and weakened due to the hemodynamic overload. The my-
ocardium will compensate until enough new collagen has been produced to restore
tensile strength and to resist the distending forces. Our findings in the TF1 and TF2
groups fit into this concept as the TF2 shows a more prominent increase in the
FIGURE 2. Immunohistochemical localization of fibronectin in right ventricular tissue
of patients with tetralogy of Fallot. Micrographs showing human right ventricular tissue
stained with rabbit–anti-human fibronectin polyclonal antibodies (as described in Materials
and Methods) from patients undergoing surgery (A) for autograft aortic root replacement
(Control), (B) for primary repair for tetralogy of Fallot (TF1), and (C) for secondary surgery
(TF2). Bar = 500 µm. (D) Significantly enhanced interstitial fibronectin staining in the TF1
group as compared to the respective controls. A semiquantitative analysis of the section was
done by two independent observers using a staining score ranging from 0 (no staining) to 4
(very strong, dark brown, staining) to assess the levels of fibronectin staining (arrows). Val-
ues are shown as mean ± SEM.
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amount of collagen as compared to TF1. Corrective surgery limits the myocardial
overload and may therefore limit the amount of damage to the myocardial collagen
matrix.6 Our study provides further evidence that myocardial architecture in patients
with TF is altered towards fibrotic state as the expression levels of extracellular ma-
trix components like collagens and fibronectin were elevated. However, further re-
search at the mRNA level would add to the notion that the gene expression of a
number of proteins involved in fibrosis was transcriptionally altered.
SUMMARY AND CONCLUSION
In the present study the degree of myocardial fibrosis at protein level in patients
with tetralogy of Fallot (TF) was examined by assessing quantitatively the expres-
sion of total collagens and fibronectin. We found a significant increase in staining
for interstitial and total collagens at primary and secondary corrective surgery as
compared to the age-matched control patients. However, immunohistochemical lo-
calization of fibronectin revealed significant increase in this protein levels at primary
correction only. Our results clearly demonstrate an increased amount of myocardial
extracellular matrix deposition resulting in tissue fibrosis in TF patients with right
ventricular hypertrophy. This vital information could be of great help in assessing
the timing of surgery as well as post-operative prognosis.
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